Skip to main content

Azitra, Inc.

For the period ended Jun 30, 2025. Filed Aug 11, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 11, 2025

AZTR$0.60-6.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Statements of Cash Flows

CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)

For the Six Months Ended June 30,
20252024
Cash flows from operating activities:
Net loss$(5,957,338)$(5,564,868)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization68,29364,953
Loss on lease modification7,726—
Amortization of right-of-use assets159,746163,901
Change in foreign currency rates on remeasurement of Canadian fixed assets—(8,526)
Stock based compensation46,43368,341
Change in fair value of warrant liability(197)(32,527)
Gain on disposal of property and equipment(1,175)—
Changes in operating assets and liabilities:
Accounts receivable23397,130
Prepaid expenses(107,984)70,238
Other assets(468)356
Tax credits receivable23,25621,848
Income tax payable/receivable(11,572)(7,399)
Accounts payable and accrued expenses40,432160,763
Operating lease liability(154,183)(156,165)
Net cash used in operating activities(5,886,798)(5,121,955)
Cash flows from investing activities:
Purchases of property and equipment(11,601)—
Proceeds from sale of property and equipment3,153—
Deferred patent costs(49,525)(155,826)
Net cash used in investing activities(57,973)(155,826)
Cash flows from financing activities
Payment of deferred offering/issuance costs—(17,550)
Principal payments on finance leases(7,838)(7,123)
Proceeds from public offerings, net1,749,3124,290,447
Proceeds from equity line of credit, net694,308—
Proceeds from exercise of stock options—19,100
Net cash provided by financing activities2,435,7824,284,874
Net change in cash and cash equivalents(3,508,989)(992,907)
Cash and cash equivalents at beginning of period4,554,7191,795,989
Cash and cash equivalents at end of period$1,045,730$803,082
Supplemental disclosure of non-cash investing and financing information:
Deferred issuance/offering costs$—$56,959
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.